Skip to main content

Market Overview

Mid-Afternoon Market Update: Crude Oil Up 2%; Biocept Shares Surge

Share:

Toward the end of trading Monday, the Dow traded down 1.84% to 23283.06 while the NASDAQ fell 0.34% to 8,126.05. The S&P also fell, dropping 1.49% to 2,748.23.

The U.S. is the epicenter of the coronavirus pandemic with the highest number of cases and deaths around the world. U.S. reported a total of 557,500 coronavirus cases with around 22,100 deaths. Spain confirmed a total of over 169,400 coronavirus cases with 17,400 deaths, while Italy reported a total of at least 156,300 confirmed cases and 19,800 deaths. In total, there were at least 1,859,000 cases of COVID-19 worldwide with over 114,900 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer discretionary shares climbed 0.4% on Monday. Meanwhile, top gainers in the sector included Kandi Technologies Group, Inc. (NASDAQ: KNDI), up 30%, and Nautilus, Inc. (NYSE: NLS), up 28%.

In trading on Monday, real estate shares fell 4.3%.

Top Headline

The Organization of the Petroleum Exporting Countries and allies agreed to long-awaited production cuts in a Sunday meeting.

The 9.7 million barrels per day cut (mb/d) fell below the market expectations. The meeting effectively ended a price war between oil powerhouses Saudi Arabia and Russia started in March. OPEC+ proposed a 10 mb/d in its last meeting on Thursday, but Mexico disagreed with the 400,000 mb/d it was asked to cut. Under the latest deal, the country is only required to cut 100,000 mb/d.

Equities Trading UP

SCWorx Corp. (NASDAQ: WORX) shares shot up 454% to $12.68. SCWorks said it has received a committed purchase order from Rethink My Healthcare —a virtual healthcare network —for 2 million COVID-19 rapid testing units. The order also carries the provision for additional weekly orders of 2 million units for 23 weeks. The order is valued at $35 million per week, accoridng to SCWorks.

Shares of Can-Fite BioPharma Ltd. (NYSE: CANF) got a boost, shooting 36% to $1.97 after the company announced it has received approval to initiate a pilot clinical study of its drug candidate, Piclidenoson, for the treatment of moderate-to-severe symptoms in coronavirus infected patients.

Biocept, Inc. (NASDAQ: BIOC) shares were also up, gaining 77% to $0.6301 after the company said in a Thursday press release that it intends to begin accepting physician-ordered COVID-19 molecular diagnostic testing requests for processing beginning April 15.

Equities Trading DOWN

Sabre Corporation (NASDAQ: SABR) shares tumbled 19% to $5.65 after the company reported offerings of senior secured notes and senior exchangeable notes.

Shares of AMC Entertainment Holdings, Inc. (NYSE: AMC) were down 20% to $2.0739. AMC is in talks to hire bankruptcy law firm Weil Gotshal as theaters shutdown since mid-March due to coronavirus, the NY Post reported.

Qualstar Corporation (NASDAQ: QBAK) was down, falling 19% to $1.99 after the company reported plans to delist from the NASDAQ and deregister its common stock.

Commodities

In commodity news, oil traded up 2% to $23.22, while gold traded up 0.6% to $1,763.00.

Silver traded down 3.1% Monday to $15.56, while copper rose 2.1% to $2.3065.

Euro zone

European markets were closed today for the Easter Monday holiday.

Economics

On the economics calendar Monday, there is no important data due out.

 

Related Articles (BIOC + AMC)

View Comments and Join the Discussion!

Posted-In: Mid-Afternoon Market UpdateNews Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com